FDA's new-drug approvals to reach at least 21 this year

12/21/2008 | Houston Chronicle (tiered subscription model)

The FDA is poised to clear at least 21 new medicines this year, increasing from 18 in 2007, despite the agency's failure to meet review deadlines for at least 15 treatments. Industry executives cited tougher approval standards as one reason for the delays. John Jenkins, director of the FDA's Office of New Drugs, said the agency evaluates "each application on its merits."

View Full Article in:

Houston Chronicle (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC